Cargando…
Targeting PSMD14 inhibits melanoma growth through SMAD3 stabilization
Although melanoma therapy is improved by novel molecular targeted reagents, including vemurafenib, aberrant proliferation and early metastasis remain obstacles for melanoma; therefore, novel target molecules for melanoma need to be identified. In this study, we focused on deubiquitinating enzymes, w...
Autores principales: | Yokoyama, Satoru, Iwakami, Yusuke, Hang, Zhao, Kin, Ryoei, Zhou, Yue, Yasuta, Yutaka, Takahashi, Atsushi, Hayakawa, Yoshihiro, Sakurai, Hiroaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7644625/ https://www.ncbi.nlm.nih.gov/pubmed/33154524 http://dx.doi.org/10.1038/s41598-020-76373-y |
Ejemplares similares
-
P38 pathway as a key downstream signal of connective tissue growth factor to regulate metastatic potential in non‐small‐cell lung cancer
por: Kato, Shinichiro, et al.
Publicado: (2016) -
COP9 signalosome subunit 5 regulates cancer metastasis by deubiquitinating SNAIL
por: Watanabe, Kensuke, et al.
Publicado: (2018) -
The prognostic role of PSMD14 in head and neck squamous cell carcinoma
por: Schnoell, Julia, et al.
Publicado: (2022) -
The prognostic value of USP14 and PSMD14 expression in non-small cell lung cancer
por: Lei, Jian, et al.
Publicado: (2021) -
Upregulation of deubiquitinase PSMD14 in lung adenocarcinoma (LUAD) and its prognostic significance
por: Zhang, Ling, et al.
Publicado: (2020)